Trademark: 90811775
Word
ENSEMBLE
Status
Dead
Status Code
602
Status Date
Thursday, August 31, 2023
Serial Number
90811775
Mark Type
4000
Filing Date
Monday, July 5, 2021
Abandoned Date
Monday, July 31, 2023

Trademark Owner History

Classifications
9 Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers
5 Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use
1 Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression of for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
10 Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers
42 Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes

Trademark Events
Aug 31, 2023
Abandonment Notice E-Mailed - Failure To Respond
Aug 31, 2023
Abandonment Notice Mailed - Failure To Respond
Aug 31, 2023
Abandonment - Failure To Respond Or Late Response
Apr 28, 2023
Notification Of Final Refusal Emailed
Apr 28, 2023
Final Refusal E-Mailed
Apr 28, 2023
Final Refusal Written
Mar 28, 2023
Teas/Email Correspondence Entered
Mar 27, 2023
Correspondence Received In Law Office
Mar 27, 2023
Teas Response To Office Action Received
Sep 28, 2022
Notification Of Non-Final Action E-Mailed
Sep 28, 2022
Non-Final Action E-Mailed
Sep 28, 2022
Non-Final Action Written
Sep 1, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Correspondence Received In Law Office
Aug 31, 2022
Teas Response To Office Action Received
Mar 7, 2022
Notification Of Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action Written
Feb 28, 2022
Assigned To Examiner
Sep 14, 2021
New Application Office Supplied Data Entered
Jul 8, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24